MedTrace Logo

Effects of Gabapentin in the Treatment of Neuropathic Pain on Driving Performance and Cognition

NCT00189072 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2005-09-16

No results posted yet for this study

Summary

The aim of this study was to explore the effects of pain on the one hand and the effects of treatment of pain with gabapentin (900, 1200, 1800 or 2400 mg) on the other hand on actual driving performance and several laboratory tests in patients with neuropathic pain. It was hypothesized that gabapentin might influence performance after acute but not after subchronic administration.

Conditions

  • Chronic Neuropathic Pain

Interventions

DRUG

gabapentin

Sponsors & Collaborators

  • Utrecht University

    collaborator OTHER

  • UMC Utrecht

    lead OTHER

Principal Investigators

  • Edmund Volkerts, PhD · Utrecht University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
30 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-04-30

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00189072 on ClinicalTrials.gov